Page last updated: 2024-08-22

camptothecin and cerulenin

camptothecin has been researched along with cerulenin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Choe, E; Choi, YH; Jeong, NY; Lee, HJ; Lee, JS; Oh, S; Park, BS; Yoo, KS; Yoo, YH	1

Other Studies

2 other study(ies) available for camptothecin and cerulenin

Article	Year
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
Fatty acid synthase inhibitor cerulenin inhibits topoisomerase I catalytic activity and augments SN-38-induced apoptosis. Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:2 Topics: Apoptosis; Camptothecin; Cell Survival; Cerulenin; Chromones; DNA Topoisomerases, Type I; Drug Synergism; Fatty Acid Synthases; Humans; Irinotecan; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Topoisomerase I Inhibitors; Tumor Cells, Cultured	2013

Article

Year

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012

Fatty acid synthase inhibitor cerulenin inhibits topoisomerase I catalytic activity and augments SN-38-induced apoptosis.

Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:2

Topics: Apoptosis; Camptothecin; Cell Survival; Cerulenin; Chromones; DNA Topoisomerases, Type I; Drug Synergism; Fatty Acid Synthases; Humans; Irinotecan; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Topoisomerase I Inhibitors; Tumor Cells, Cultured

2013